Cogent Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COGT and other ETFs, options, and stocks.

About COGT

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. 

CEO
Andrew R. Robbins
CEOAndrew R. Robbins
Employees
205
Employees205
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2014
Founded2014
Employees
205
Employees205

COGT Key Statistics

Market cap
1.80B
Market cap1.80B
Price-Earnings ratio
-5.40
Price-Earnings ratio-5.40
Dividend yield
Dividend yield
Average volume
1.25M
Average volume1.25M
High today
$13.47
High today$13.47
Low today
$12.84
Low today$12.84
Open price
$13.10
Open price$13.10
Volume
587.50K
Volume587.50K
52 Week high
$13.50
52 Week high$13.50
52 Week low
$3.72
52 Week low$3.72

Analyst ratings

77%

of 13 ratings
Buy
76.9%
Hold
23.1%
Sell
0%

People also own

Based on the portfolios of people who own COGT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.